2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow Keratoacanthoma: new trials by email Literature Review of Keratoacanthoma trials Research Report on Keratoacanthoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Intralesional Versus Intramuscular Methotrexate for Non-melanoma Skin Cancers Methotrexate - Non-melanoma Skin Cancers | Phase 2 | Completed | Zagazig University | 60 | 2020-07-06 | 2022-04-07 |
| Study of TVEC in Patients With Cutaneous Squamous Cell Cancer Injection of TVEC into target lesions - week 1-2, Injection of TVEC into target lesions 3wks after 1st injection, Injection of TVEC into target lesions 2wks after 2nd injection - Squamous Cell Carcinoma, Skin Cancer | Phase 2 | Completed | University of Arizona | 11 | 2018-12-20 | 2024-10-09 |
Carcinoma, Squamous Cell (2) · Carcinoma, Basal Cell (1) · Skin Neoplasms (1)
Carcinoma (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms, Glandular and Epithelial (2) · Neoplasms, Squamous Cell (2) · Skin Diseases (2) · Skin and Connective Tissue Diseases (2) · Neoplasms by Site (1) · Neoplasms, Basal Cell (1)
Methotrexate (1)
University of Arizona (1) · Zagazig University (1)
Egypt (1) · United States (1)
Clara Curiel, MD (1)